Incidence of cardiovascular and cerebrovascular events associated with sirolimus use after liver transplantation

Transplantation Proceedings

Volumn 47, Issue 2, 2015, Pages 460-464

  Weick, A ^a   Chacra, W ^a   Kuchipudi, A ^a   Elbatta, M ^a   Divine, G ^a   Burmeister, C ^a   Moonka, D ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS; RAPAMYCIN; CALCINEURIN INHIBITOR; IMMUNOSUPPRESSIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DIARRHEA; DRUG ERUPTION; DRUG USE; DRUG WITHDRAWAL; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; INCIDENCE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUTROPENIA; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SURVIVAL; AGED; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; COMPARATIVE STUDY; EVALUATION STUDY; KAPLAN MEIER METHOD; MIDDLE AGED; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATIONS; STROKE;

ADULT; AGED; CALCINEURIN INHIBITORS; CORONARY ARTERY DISEASE; EVEROLIMUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SIROLIMUS; STROKE;

EID: 84926136705     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2014.11.036     Document Type: Article

References (9)

1. A.O. Ojo, P.J. Held, F.K. Port, R.A. Wolfe, A.B. Leichtman, and E.W. Young Chronic renal failure after transplantation of a nonrenal organ N Engl J Med 349 2003 931 940
2. L. Teperman, D. Moonka, A. Sebastian, L. Sher, P. Marotta, and C. Marsh Calcineurin inhibitor-free mycophenolate mofetil/sirolimus maintenance in liver transplantation: the randomized Spare-the-Nephron trial Liver Transpl 19 2013 675 689
3. C.J. Watson, A.E. Gimson, G.J. Alexander, M.E. Allison, P. Gibbs, and J.C. Smith A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function Liver Transpl 13 2007 1694 1702
4. C.C. Rogers, S.R. Johnson, D.A. Mandelbrot, M. Pavlakis, T. Horwedel, and S.J. Karp Timing of sirolimus conversion influences recovery of renal function in liver transplant recipients Clin Transplant 23 2009 887 896
5. J.F. Trotter, M.E. Wachs, T.E. Trouillot, T. Bak, M. Kugelmas, and I. Kam Dyslipidemia during sirolimus therapy in liver transplant recipients occurs with concomitant cyclosporine but not tacrolimus Liver Transpl 7 2001 401 408
6. I. Morard, J. Dumortier, L. Spahr, A. Hadengue, P. Majno, and P. Morel Conversion to sirolimus-based immunosuppression in maintenance liver transplantation patients Liver Transpl 13 2007 658 664
7. G. McKenna, J. Trotter, E. Klintmalm, R. Ruiz, N. Onaca, and G. Testa Sirolimus and cardiovascular disease risk in liver transplantation Transplantation 95 2013 215 221
8. A. Alejaldre, R. Delgado-Medoros, M. Angel Santos, and J. Marti-Fabregas Cerebrovascular complications after heart transplantation Curr Cardiol Rev 6 2010 214 217
9. J.J. Augustine, K.A. Bodziak, and D.E. Hricik Use of sirolimus in solid organ transplantation Drugs 67 2007 369 391